hexamethonium has been researched along with Neoplasms in 3 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gulliford, M | 1 |
| Charlton, J | 1 |
| Bhattarai, N | 1 |
| Rudisill, C | 1 |
| Bříza, T | 1 |
| Králová, J | 1 |
| Dolenský, B | 1 |
| Rimpelová, S | 1 |
| Kejík, Z | 1 |
| Ruml, T | 1 |
| Hajdúch, M | 1 |
| Džubák, P | 1 |
| Mikula, I | 1 |
| Martásek, P | 1 |
| Poučková, P | 1 |
| Král, V | 1 |
| GUIDETTI, B | 1 |
| ALVISI, C | 1 |
3 other studies available for hexamethonium and Neoplasms
| Article | Year |
|---|---|
Social and material deprivation and the cost-effectiveness of an intervention to promote physical activity: cohort study and Markov model.
Topics: Adult; Cardiovascular Diseases; Chronic Disease; Cohort Studies; Cost-Benefit Analysis; Cultural Dep | 2014 |
Striking antitumor activity of a methinium system with incorporated quinoxaline unit obtained by spontaneous cyclization.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclization; Hexamethonium; Mice; Neoplasms; Quino | 2015 |
[Hexamethonium in neurosurgery and neurology].
Topics: Analgesia; Anesthesia; Anesthesia and Analgesia; Brain; Brain Neoplasms; Hexamethonium; Hypotension; | 1954 |